Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients
Alimentary Pharmacology and Therapeutics
Saved in:
Main Authors: | Lim, L.L., Wai, C.T., Lee, Y.M., Lim, S.G., Kong, H.L., Lim, R., Koay, E. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117822 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients
by: Lim, L.L., et al.
Published: (2016) -
Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore [4]
by: Wai, C.T., et al.
Published: (2014) -
Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore [4]
by: Wai, C.T., et al.
Published: (2016) -
Prophylactic strategies for Hepatitis B patients undergoing liver transplant: A cost-effectiveness analysis
by: Dan, Y.Y., et al.
Published: (2016) -
Prophylactic strategies for Hepatitis B patients undergoing liver transplant: A cost-effectiveness analysis
by: Dan, Y.Y., et al.
Published: (2011)